Answers are grounded in this paper and cite their sources.
Purpose of review Pregnancy represents a critical window during which maternal metabolism, placental function, and fetal growth are tightly coordinated. This review summarizes recent advances in tryptophan metabolism across the maternal–placental–fetal axis, with particular emphasis on gestational regulation, placental metabolism, fetal exposure to tryptophan-derived metabolites, and implications for early neurodevelopment. Recent findings Tryptophan metabolism extends beyond serotonin synthesis, with the kynurenine pathway and its bioactive metabolites emerging as key regulators of immune tolerance and signaling. The placenta functions as an active metabolic interface, controlling fetal exposure to tryptophan-derived compounds. In parallel, the maternal gut microbiota modulates systemic tryptophan availability and produces indole metabolites that may affect placental physiology and developmental pathways. These data support an integrated network linking nutritional states, microbial metabolism, and fetal development. Summary Tryptophan metabolism is increasingly recognized as a central component of gestational metabolic programming rather than a single nutrient-dependent pathway. Interactions among maternal diet, immune and endocrine status, placental transport and metabolism, and microbiota may provide opportunities for biomarker discovery and targeted nutritional or microbiota-based interventions to improve maternal and neurodevelopmental outcomes.
No takes yet. Share an insight, caveat, or question.
Fortunato et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: